Now that EPA has completed the risk evaluation of 1,4-Dioxane and found that several consumer uses do not present an unreasonable risk, what happens next? Hear from the experts on the findings of the 1,4-dioxane risk evaluation, preemption under the Lautenberg Chemical Safety Act, and the potential implications to state and EPA activity involving 1,4-dioxane.
- Steve Bennett, SVP, Scientific & Regulatory Affairs, HCPA
- Jim Jones, Consultant, James J. Jones Environmental
- Michael Boucher, Partner, Crowell & Moring